Approval · Notice of Compliance 8016 · 2006
MYOCET: Notice of Compliance 8016
Issued June 7, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8016
- Date
- June 7, 2006
- Company
- Sopherion Therapeutics, Inc.East Brunswick, New Jersey, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New source of bulk active ingredient; change to the manufacturing source and formulation of the active pharmaceutical ingredient
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MYOCET | Not yet assigned | — |
Medicinal ingredients
- DOXORUBICIN HYDROCHLORIDE 2 MG per ML